The document, called "The National Technology Roadmap for Pandemic Response and Recovery," is the first from the manufacturing sphere, according to ARMI. It outlines ways to improve pandemic response through resilient supply chains, flexible and robust manufacturing, effective distribution and access to necessary products, sound data infrastructure, and accelerated regulatory processes, ARMI said.

ARMI, a nonprofit organization, leads BioFabUSA, a Department of Defense-sponsored Manufacturing USA Institute. The public-private partnership is dedicated to the advanced biomanufacturing and commercialization of cells, tissues, and tissue-related technologies, developing a robust supply chain to support biomanufacturing, and creating a ready and trained workforce for biomanufacturing.

Pluristyx supports Kiadis' COVID-19 NK cell therapy
Pluristyx will be supporting Kiadis Pharma and the Advanced Regenerative Manufacturing Institute's BioFabUSA program by providing services for the research...